The Epigenetic Drug 5-Azacytidine Interferes with Cholesterol and Lipid Metabolism-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Epigenetic Drug 5-Azacytidine Interferes with Cholesterol and Lipid Metabolism

Published:2014-07 Issue:27 Volume:289 Page:18736-18751
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Poirier Steve,Samami Samaneh,Mamarbachi Maya,Demers Annie,Chang Ta Yuan,Vance Dennis E.,Hatch Grant M.,Mayer Gaétan

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference56 articles.

1. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals;Jaenisch;Nat. Genet,2003

2. DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer;Gnyszka;Anticancer Res,2013

3. Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia;Estey;Leukemia,2013

4. A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines;Hollenbach;PLoS One,2010

5. The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells;Flotho;Leukemia,2009

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The DNA methyltransferase inhibitor decitabine blunts the response to a high-animal fat and protein diet in mice;Journal of Lipid Research;2024-08

2. Nanoparticles loaded with the DNA methyltransferase inhibitor SGI-1027 decrease murine atherosclerosis and inflammation in cultured human macrophages;Exploration of Cardiology;2024-04-10

3. Upregulated cholesterol biosynthesis facilitates the survival of methylation-retaining AML cells following decitabine treatment;2024-02-01

4. An Overview on Lipid Droplets Accumulation as Novel Target for Acute Myeloid Leukemia Therapy;Biomedicines;2023-11-30

5. Macrophage-targeted DNA methyltransferase inhibitor SGI-1027 decreases atherosclerosis in ApoE-null mice;2023-08-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3